BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Issa H. Safety of pegylated interferon and ribavirin therapy for chronic hepatitis C in patients with sickle cell anemia. World J Hepatol 2010; 2(5): 180-184 [PMID: 21160993 DOI: 10.4254/wjh.v2.i5.180]
URL: https://www.wjgnet.com/1948-5182/full/v2/i5/180.htm
Number Citing Articles
1
AbdullahS Alghamdi, FaisalM Sanai, Mona Ismail, Hamdan Alghamdi, Khalid Alswat, Adel Alqutub, Ibrahim Altraif, Hemant Shah, FalehZ Alfaleh. SASLT practice guidelines: Management of hepatitis C virus infectionSaudi Journal of Gastroenterology 2012; 18(7): 1 doi: 10.4103/1319-3767.101155
2
Hossein Ghaderi-Zefrehi, Mohammad Gholami-Fesharaki, Heidar Sharafi, Farzin Sadeghi, Seyed Moayed Alavian. The Distribution of Hepatitis C Virus Genotypes in Middle Eastern Countries: A Systematic Review and Meta-AnalysisHepatitis Monthly 2016; 16(9) doi: 10.5812/hepatmon.40357
3
Roberta D’Ambrosio, Erika Poggiali, Maria Domenica Cappellini. Treating hepatitis C in patients with hemoglobinopathiesExpert Opinion on Orphan Drugs 2015; 3(11): 1267 doi: 10.1517/21678707.2015.1086333
4
Gil Ben Yakov, Disha Sharma, Hawwa Alao, Pallavi Surana, Devika Kapuria, Ohad Etzion, Matthew M. Hsieh, John F. Tisdale, Courtney D. Fitzhugh, David E. Kleiner, Elliot B. Levy, Richard Chang, Elenita Rivera, Amy Huang, Christopher Koh, Theo Heller. Vibration Controlled Transient Elastography (Fibroscan®) in sickle cell liver disease ‐ could we strike while the liver is hard?British Journal of Haematology 2019; 187(1): 117 doi: 10.1111/bjh.16047
5
Suhair M. Abozaid, Mohamed Shoukri, Ahmad Al-Qahtani, Mohammed N. Al-Ahdal. Prevailing genotypes of hepatitis C virus in Saudi Arabia: a systematic analysis of evidenceAnnals of Saudi Medicine 2013; 33(1): 1 doi: 10.5144/0256-4947.2013.1
6
Sanaa M. Kamal, Ahmed M. Fouad. Hepatitis C in Developing Countries2018; : 177 doi: 10.1016/B978-0-12-803233-6.00014-X
7
Adnan Agha, Rafaat Chakik, Mamdouh M. Abdulhadi Ali, Dib Alsaudi, Giorgio Sammito, Edoardo Giovanni Giannini. Peg-interfon alpha-2a and low-dose ribavirin for treatment of hepatitis C virus infection in patients with sickle-cell anemia in Saudi ArabiaAnnals of Saudi Medicine 2013; 33(6): 610 doi: 10.5144/0256-4947.2013.610